Ligand Pharmaceuticals, Inc. (LGND)
280.04
-6.25
(-2.18%)
USD |
NASDAQ |
Aug 24, 16:00
280.04
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals 1 Year Total Returns (Daily) : 81.99% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 81.99% |
| August 20, 2026 | 85.11% |
| August 19, 2026 | 88.69% |
| August 18, 2026 | 87.65% |
| August 17, 2026 | 93.12% |
| August 14, 2026 | 91.56% |
| August 13, 2026 | 85.14% |
| August 12, 2026 | 92.07% |
| August 11, 2026 | 96.42% |
| August 10, 2026 | 97.05% |
| August 07, 2026 | 100.3% |
| August 06, 2026 | 110.8% |
| August 05, 2026 | 123.9% |
| August 04, 2026 | 122.2% |
| August 03, 2026 | 120.0% |
| July 31, 2026 | 118.5% |
| July 30, 2026 | 119.1% |
| July 29, 2026 | 118.9% |
| July 28, 2026 | 119.6% |
| July 27, 2026 | 119.0% |
| July 24, 2026 | 126.3% |
| July 23, 2026 | 121.8% |
| July 22, 2026 | 129.7% |
| July 21, 2026 | 116.5% |
| July 20, 2026 | 111.4% |
| Date | Value |
|---|---|
| July 17, 2026 | 120.5% |
| July 16, 2026 | 128.7% |
| July 15, 2026 | 138.3% |
| July 14, 2026 | 137.1% |
| July 13, 2026 | 154.1% |
| July 10, 2026 | 153.0% |
| July 09, 2026 | 163.6% |
| July 08, 2026 | 173.5% |
| July 07, 2026 | 180.8% |
| July 06, 2026 | 179.6% |
| July 02, 2026 | 181.1% |
| July 01, 2026 | 177.2% |
| June 30, 2026 | 178.1% |
| June 29, 2026 | 175.1% |
| June 26, 2026 | 162.4% |
| June 25, 2026 | 155.7% |
| June 24, 2026 | 141.0% |
| June 23, 2026 | 143.0% |
| June 22, 2026 | 129.8% |
| June 18, 2026 | 139.8% |
| June 17, 2026 | 133.8% |
| June 16, 2026 | 121.9% |
| June 15, 2026 | 125.1% |
| June 12, 2026 | 123.3% |
| June 11, 2026 | 120.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Johnson & Johnson | 54.80% |
| Eli Lilly & Co. | 77.98% |
| Merck & Co., Inc. | 83.18% |
| Zevra Therapeutics, Inc. | 24.82% |
| Liquidia Corp. | 151.4% |